Cargando…

Mouse models and anti-HER2 therapies

Detalles Bibliográficos
Autores principales:	Hanker, Ariella B., Cook, Rebecca S., Arteaga, Carlos L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2013
Materias:	News and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3875754/ https://www.ncbi.nlm.nih.gov/pubmed/24272818

Ejemplares similares

Trastuzumab, an appropriate first-line single-agent therapy for HER2-overexpressing metastatic breast cancer
por: Arteaga, Carlos L
Publicado: (2003)

In situ single cell analysis identifies heterogeneity for PIK3CA mutation and HER2 amplification in HER2(+) breast cancer
por: Janiszewska, Michalina, et al.
Publicado: (2015)

Optical imaging of metabolism in HER2 overexpressing breast cancer cells
por: Walsh, Alex, et al.
Publicado: (2011)

Dual inhibition of Type I and Type III PI3 kinases increases tumor cell apoptosis in HER2+ breast cancers
por: Young, Christian D., et al.
Publicado: (2015)

Expression of adenoviral E1A throws the PIDD switch
por: Radke, Jay R, et al.
Publicado: (2017)

H1047R phosphatidylinositol 3-kinase mutant enhances HER2-mediated transformation via heregulin production and activation of HER3
por: Chakrabarty, Anindita, et al.
Publicado: (2010)

The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response
por: Botta, C, et al.
Publicado: (2016)

Bettina Winckler: Neuronal polarity on her mind
por: Sedwick, Caitlin
Publicado: (2010)

Towards maximising information extraction from rodent models of ocular disease
por: Davis, B M, et al.
Publicado: (2016)

Histamine: a potential cytoprotective agent to improve cancer therapy?
por: Martinel Lamas, D J, et al.
Publicado: (2015)

Evaluation of Biomarkers for HER3-targeted Therapies in Cancer
por: Karachaliou, Niki, et al.
Publicado: (2015)

Enhanced Cardiac Testing in a Dual Anti-HER2 Regimen: What Have We Learned?
por: Ewer, Michael S., et al.
Publicado: (2016)

Harnessing downstream NF-κB signalling to achieve apoptosis-inducing anti-cancer-specific activity
por: Vaccarezza, M, et al.
Publicado: (2016)

Towards comprehensive characterization of HER2 overexpression
por: Berezov, Alan, et al.
Publicado: (2006)

Novel HER2-Directed Treatments in Advanced Gastric Carcinoma: AnotHER Paradigm Shift?
por: Ricci, Angela Dalia, et al.
Publicado: (2021)

Nrf2: new insight in cell apoptosis
por: Bonay, M, et al.
Publicado: (2015)

Fat, sex and caspase-2
por: Wilson, C H, et al.
Publicado: (2016)

Considering autophagy, β-Catenin and E-Cadherin as innovative therapy aspects in AML
por: Kühn, K, et al.
Publicado: (2015)

Patterns of HER2 Gene Amplification and Response to Anti-HER2 Therapies
por: Vicario, Rocio, et al.
Publicado: (2015)

The potential of erythrocytes as cellular aging models
por: Kaestner, Lars, et al.
Publicado: (2017)

P2X(7) receptor activity regulation: the role of CD44 proteoglycan GAG chains
por: Moura, G E D D, et al.
Publicado: (2015)

Bcl-2 proteins, cell migration and embryonic development: lessons from zebrafish
por: Prudent, J, et al.
Publicado: (2015)

Depleting stabilized GOF mutant p53 proteins by inhibiting molecular folding chaperones: a new promise in cancer therapy
por: Alexandrova, Evguenia M, et al.
Publicado: (2017)

The New Physician to Her Majesty the Queen
Publicado: (1900)

Curcumin hormesis mediates a cross-talk between autophagy and cell death
por: Rainey, N, et al.
Publicado: (2015)

Loss of function of Ywhah in mice induces deafness and cochlear outer hair cell's degeneration
por: Buret, L, et al.
Publicado: (2016)

Reactivation of p53 via MDM2 inhibition
por: Kim, E S, et al.
Publicado: (2015)

Inhibitory PAS domain protein is a substrate of PINK1 and Parkin and mediates cell death in a Parkinson's disease model
por: Kasai, S, et al.
Publicado: (2015)

The Bcl2a1 gene cluster finally knocked out: first clues to understanding the enigmatic role of the Bcl-2 protein A1
por: Berberich, Ingolf, et al.
Publicado: (2017)

Novel β-carbolines inhibit Wnt/β-catenin signaling
por: Kong, L, et al.
Publicado: (2015)

Distinct roles for the cellular inhibitors of apoptosis proteins 1 and 2
por: Graber, T E, et al.
Publicado: (2011)

Trefoil factor 3 mediates resistance to apoptosis in colon carcinoma cells by a regulatory RNA axis
por: Hanisch, Carlos, et al.
Publicado: (2017)

Discovery of a novel target for renal cell carcinoma: transglutaminase 2
por: Kang, J H, et al.
Publicado: (2016)

Deciphering the true antiproliferative target of an MK2 activation inhibitor in glioblastoma
por: Brennan, P E
Publicado: (2016)

Diet-driven interferon-γ enhances malignant transformation of primary bovine mammary epithelial cells through nutrient sensor GCN2-activated autophagy
por: Xia, X-j, et al.
Publicado: (2016)

The esoteric roles of Bcl-2 family proteins in glucose homeostasis and cell survival
por: Pfeiffer, S, et al.
Publicado: (2015)

Pro-death activity of a BH3 domain in an aquaporin from the protozoan parasite Leishmania
por: Genes, Carlos Mario, et al.
Publicado: (2016)

A transcription factor 7-like 1-lipocalin 2 axis in the differentiation of keratinocytes
por: Liu, Y, et al.
Publicado: (2016)

BCL2: a 30-year tale of life, death and much more to come
por: Pentimalli, Francesca
Publicado: (2018)

Trastuzumab beyond progression in HER2‐positive metastatic breast cancer
por: Al‐Naqqash, Manwar, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hjnn8d6dv65pv0o7kb414ngf4m